Use of Bone-Modifying Agents in Australian Men with Castration-Resistant Prostate Cancer (CRPC)

被引：0
|
作者：
Anton, Angelyn [1 ]
Parente, Phillip [2 ,3 ]
Azad, Arun [4 ]
Weickhardt, Andrew [5 ]
Wong, Shirley [6 ]
Shapiro, Julia [3 ]
Torres, Javier [7 ]
Parnis, Francis [8 ]
Semira, Christine [1 ]
Gibbs, Peter [1 ,6 ]
Tran, Ben [1 ,9 ]
Pezaro, Carmel [2 ,3 ]
机构：
[1] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia
[2] Eastern Hlth, Melbourne, Vic, Australia
[3] Monash Univ, Melbourne, Vic, Australia
[4] Monash Hlth, Melbourne, Vic, Australia
[5] Olivia Newton John Canc Wellness & Res Ctr, Melbourne, Vic, Australia
[6] Western Hlth, Melbourne, Vic, Australia
[7] Goulburn Valley Hlth, Melbourne, Vic, Australia
[8] Adelaide Canc Ctr, Adelaide, SA, Australia
[9] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
abs100
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [21] Second line therapy for castration-resistant prostate cancer (CRPC)
    Molitor, B.
    Boergermann, C.
    UROLOGE, 2012, 51 (03): : 357 - 362
  • [22] Prognostic significance of antihypertensive agents in men with castration-resistant prostate cancer
    Shiota, Masaki
    Kobayashi, Takeshi
    Kashiwagi, Eiji
    Takeuchi, Ario
    Inokuchi, Junichi
    Tatsugami, Katsunori
    Eto, Masatoshi
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (11) : 813.e21 - 813.e26
  • [23] Sequencing of agents in castration-resistant prostate cancer
    Lorente, David
    Mateo, Joaquin
    Perez-Lopez, Raquel
    de Bono, Johann S.
    Attard, Gerhardt
    LANCET ONCOLOGY, 2015, 16 (06): : E279 - E292
  • [24] Sequencing of Agents for Castration-Resistant Prostate Cancer
    Hurwitz, Michael
    Petrylak, Daniel P.
    ONCOLOGY-NEW YORK, 2013, 27 (11): : 1144 - +
  • [25] Efficacy of a novel cytotoxic polybisphosphonate for treatment of bone metastasis in castration-resistant prostate cancer (CRPC).
    Nilsson, Sten
    Lindberg, Henriette
    Thellenberg-Karlsson, Camilla
    Nyman, Claes
    Marquez, Marcela
    Lennartsson, Lena
    Blom, Rene
    Castellanos, Enrique
    Holmberg, Anders R.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [26] Castration-Resistant Prostate Cancer (CRPC): understanding the mechanisms and implications for management
    Bessede, T.
    Malavaud, B.
    Staerman, F.
    Culine, S.
    PROGRES EN UROLOGIE, 2013, 23 : 6 - 11
  • [27] IMPACT OF BONE METASTASES (BM) ON THE HUMANISTIC BURDEN IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
    Hechmati, G.
    Arellano, J.
    Haynes, I
    Worsfold, A.
    Rider, A.
    VALUE IN HEALTH, 2013, 16 (03) : A148 - A148
  • [28] Efficacy of a novel cytotoxic polybisphosphonate for treatment of bone metastasis in castration-resistant prostate cancer (CRPC).
    Nilsson, Sten
    Lindberg, Henriette
    Thellenberg-Karlsson, Camilla
    Nyman, Claes
    Marquez, Marcela
    Lennartsson, Lena
    Blom, Rene
    Castellanos, Enrique
    Holmberg, Anders R.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] COSTS AT THE END OF LIFE FOR PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
    Alemayehu, B.
    Parry, D.
    Engel-Nitz, N. M.
    Kulakodlu, M.
    Nathan, F.
    VALUE IN HEALTH, 2011, 14 (03) : A161 - A162
  • [30] Kaiso as a novel therapeutic target in castration-resistant prostate cancer (CRPC)
    Lin, Hui-Xian
    Wang, Honghe
    White, Jason
    Karanam, Balasubramanyam
    Ghebremedhin, Anghesom
    Addai, Benjamin Adu
    Grizzle, William E.
    Yates, Clayton
    CANCER RESEARCH, 2019, 79 (13)
12345